[144] Broadcom Inc. SEC Filing
Rhea-AI Filing Summary
Form 144 notice for Broadcom Inc. (AVGO) documents a proposed sale of 2,504 shares of Broadcom common stock through Charles Schwab & Co., Inc., with an aggregate market value of $902,412.00. The filing records the securities as acquired and payable on 09/16/2025 arising from a Restricted Stock Lapse and indicates Equity Compensation as the nature of payment. The broker listed is Charles Schwab & Co., Inc., and the proposed sale date is 09/16/2025 on NASDAQ. The filer reports no securities sold in the past three months and includes the standard attestation that no undisclosed material adverse information is known.
Positive
- Compliance filing completed with required Form 144 details including broker, share count, aggregate value, and acquisition information
- Transaction origin explicitly stated as a Restricted Stock Lapse and funded via Equity Compensation
Negative
- None.
Insights
TL;DR: Insider equity award converted to unrestricted shares and a small block is being registered for sale.
The filing shows a grant-derived restricted stock lapse where 2,504 shares became eligible for sale and are being reported via Form 144 with Charles Schwab as the broker. The filing is procedural and confirms no reported sales in the prior three months. From a compliance perspective, the notice meets Rule 144 disclosure by documenting acquisition date, nature of acquisition, broker, aggregate market value, and proposed sale date.
TL;DR: Routine disclosure of saleability following equity vesting; no other governance events disclosed.
The statement that the shares were acquired through a Restricted Stock Lapse and paid via Equity Compensation is consistent with executive or employee equity vesting. The filing includes the required representation that the seller is not aware of undisclosed material adverse information. There are no disclosures here of leadership changes, related-party issues, or material transactions beyond the listed sale notice.